US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist

0.588
+0.018+3.19%

Close Jan 3 16:00 ET

0.600
+0.012+2.01%

Post 17:16 ET

22.51MMarket Cap-0.34P/E (TTM)

Bolt Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bolt Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 400.000K	--
--	2024/Q4	-- / 790.000K	--
--	2024/Q3	1.141M / 1.263M	--
--	2024/Q2	1.275M / 891.500K	--
May 14, 2024	2024/Q1	5.274M / 2.251M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 400.000K--

--2024/Q4-- / 790.000K--

--2024/Q31.141M / 1.263M--

--2024/Q21.275M / 891.500K--

May 14, 20242024/Q15.274M / 2.251M--

Unlock Free Earnings Estimates

Open Account

Bolt Biotherapeutics Earnings Reports

Bolt Biotherapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:20 ET

Bolt Biotherapeutics | 8-K: Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024 16:15 ET

Bolt Biotherapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13, 2024 16:14 ET

Bolt Biotherapeutics | 8-K: Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024 16:14 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data